mortality/aging
|
• cis-double heterozygotes died at 15 weeks and trans-double heterozygotes died at 25 weeks
|
neoplasm
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
|
• both cis- and trans-double heterozygotes developed sarcomas
|
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
integument
|
• developed in cis-double heterozygotes
|
muscle
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
nervous system
|
• developed in cis-double heterozygotes
|
|
• developed in cis-double heterozygotes
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| neurofibromatosis 1 | DOID:0111253 |
OMIM:162200 |
J:58877 | |


Analysis Tools